Open-label Trial Evaluating Four Oral Hygiene Regimens Using a Manual Toothbrush, Toothpaste, and Mouthwash
Evaluation of the Tolerability, Safety of Use, and Efficacy of Cosmetic Products for the Oral Care. In Use Test Under Dentist Control
1 other identifier
interventional
84
1 country
2
Brief Summary
The purpose of this open-label, randomized controlled clinical trial, is to provide preliminary clinical data (efficacy on plaque and gingival sensitivity, and safety and tolerability of two types of toothpaste, a mouthwash, and a specifically custom-designed toothbrush used for 28 days), as well as descriptive data on the effects of the products on oral microbiota rebalancing and patient acceptability. Eighty-four participants with a history of poor oral hygiene are visited at baseline and after 28 days of administration of the tested products. The control group consisted of 12 participants who continued to use their oral care products without changing their normal routine. At baseline and at the end of treatment (final visit), the oral microbiome is also evaluated in a group of 12 subjects allocated randomly.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2022
Shorter than P25 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 17, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 26, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 9, 2022
CompletedFirst Submitted
Initial submission to the registry
July 20, 2023
CompletedFirst Posted
Study publicly available on registry
August 21, 2023
CompletedMay 22, 2025
May 1, 2025
2 months
July 20, 2023
May 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Gums sensitivity
Change from baseline to day 14 and 28 days assessed by the Investigator during the dentist examination using a 10 cm visual analogue scale (VAS) where 0 is absence of sensitivity and 10 indicates the maximum of sensitivity.
28 days
Rate of gingival irritations
Change from baseline to 14 and 28 days assessed by the Investigator during the dentist examination as follows: (Yes presence of gingival irritation; No = absence of gingival irritation).
28 days
Rate of oral mucosa lesions
Change from baseline to 14 and 28 days assessed by the Investigator during the dentist examination as follows: (Yes presence of oral mucosa lesion; No = absence of oral mucosa lesion).
28 days
Dental plaque assessment
Change from T0 (at the baseline at visit, performed three hours after the last teeth brushing) to Timm (evaluation done immediately after the first product use). The evaluation is carried out by means of an erythrosine-based disclosing tablet, which allows to quantify the presence of plaque on the teeth. First, the dentist gives the tablet to the subjects, who are asked to chew it thoroughly in their mouths. Then, the subjects are asked to rub the chewed particles of the tablets on their teeth with their tongue and swish the accumulated saliva in their mouth for about 60 seconds before rinsing with water. The releasing tablet stains the plaque on the teeth.
1 day
Teeth colour assessment
Change from baseline to 14 and 28 days as assessed by the investigator during the dentist's examination comparing the subjects' teeth with those shown on the VITAPAN® Score. The scoring system consists of a series of 16 "artificial teeth" in 16 different colors, each of which is associated with an alphanumeric code representing the entire chromatic space of natural teeth. It classifies tooth color into 4 families of shades as follows: reddish-brownish (A1, A2, A3, A3.5, A4), reddish-yellowish (B1, B2, B3, B4), grayish (C1, C2, C3, C4) and reddish-grey (D2, D3, D4).
28 days
Secondary Outcomes (3)
Self-assessment questionnaire
28 days
Oral microbiota analysis
28 days
Serious Adverse Events/Adverse Events
14 days
Study Arms (5)
Group 1 (20 subjects)
OTHERusing the delicate mint toothpaste "Dentifricio gel tau-marin® Menta Delicata".
Group 2 (12 subjects)
OTHERusing of the mint toothpaste "Dentifricio gel tau-marin® Menta".
Group 3 (20 subjects)
OTHERusing the mint mouthwash "Collutorio tau-marin® Menta.
Group 4 (20 subjects)
OTHERusing the delicate mint toothpaste "Dentifricio gel tau-marin® Menta Delicata", mint mouthwash "Collutorio tau-marin® Menta".
Group 5 (12 subjects)
OTHERcontinuing to use their routine oral hygiene products.
Interventions
the toothpaste is used with a standard toothbrush without any claims 3 times a day after the main meals for 28 days.
the mint toothpaste and mouthwash are used with the scalar toothbrush 33 medium with antibacterial " Spazzolino tau-marin®" 3 times a day after the main meals for 28 days.
subjects of this group will use their routine oral hygiene products.
Eligibility Criteria
You may qualify if:
- Healthy Caucasian males and females aged ≥ 18 to ≤ 65 years included.
- Proper oral hygiene not performed verified with Simplified Oral Hygiene Index (OHI-S) (score ≥ 2) and a questionnaire on oral habit.
- Patients able to comply with the requirements for the study and freely willing to provide written informed consent to the collection of their data.
- Registered with Italian National Health Service (NHS).
- Ability to understand the language used in the investigation center and to comply with the study procedures.
- Unbanned pharmacological therapy stable for at least one month without any changes during the study.
- Commitment not to change the daily routine and lifestyle.
You may not qualify if:
- Allergies or sensitivity to oral care products, cosmetic products, drugs, patch or medical devices.
- Any oral cavity condition inappropriate for participation.
- Gums bleeding due to pathologies/pharmacological treatment.
- Concomitant or during the last week antibiotic therapy.
- Smokers (≥5 cigarettes/day).
- Acute, chronic or progressive diseases/illness/conditions able to interfere with the outcome of the study or considered dangerous or incompatible with the study requirements.
- Pathological staining of teeth.
- Breast-feeding, pregnancy, or women of child-bearing age unwilling to take the necessary precautions to avoid pregnancy during the study.
- Planning to participate or participation in other clinical trials withing 30 days.
- Hospitalization/planned hospitalization in a health or social facility.
- Deprivation of freedom by administrative or legal decision or under guardianship
- Inability to be contacted in case of emergency.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Biokosmes Srllead
- Opera CRO, a TIGERMED Group Companycollaborator
Study Sites (2)
Studio D. Cattaneo
San Genesio ed Uniti, Pavia, 27010, Italy
Complife Italia Srl
San Martino Siccomario, Pavia, 27028, Italy
Related Publications (5)
Willis JR, Gabaldon T. The Human Oral Microbiome in Health and Disease: From Sequences to Ecosystems. Microorganisms. 2020 Feb 23;8(2):308. doi: 10.3390/microorganisms8020308.
PMID: 32102216BACKGROUNDAbdulkareem AA, Al-Taweel FB, Al-Sharqi AJB, Gul SS, Sha A, Chapple ILC. Current concepts in the pathogenesis of periodontitis: from symbiosis to dysbiosis. J Oral Microbiol. 2023 Apr 2;15(1):2197779. doi: 10.1080/20002297.2023.2197779. eCollection 2023.
PMID: 37025387BACKGROUNDKilian M, Chapple IL, Hannig M, Marsh PD, Meuric V, Pedersen AM, Tonetti MS, Wade WG, Zaura E. The oral microbiome - an update for oral healthcare professionals. Br Dent J. 2016 Nov 18;221(10):657-666. doi: 10.1038/sj.bdj.2016.865.
PMID: 27857087BACKGROUNDRajendiran M, Trivedi HM, Chen D, Gajendrareddy P, Chen L. Recent Development of Active Ingredients in Mouthwashes and Toothpastes for Periodontal Diseases. Molecules. 2021 Apr 1;26(7):2001. doi: 10.3390/molecules26072001.
PMID: 33916013BACKGROUNDRosu S, Benatti P, Bianco S, Barattini DF, Nobile V, Mellai M, Cattaneo D. Pilot, open-label, randomized controlled clinical trial evaluating 4 oral hygiene regimens using a manual toothbrush, toothpaste, and mouthwash. Gen Dent. 2024 Jul-Aug;72(4):62-71.
PMID: 38905608RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dario Cattaneo, DDS
San Genesio ed Uniti, Pavia (Italy)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 20, 2023
First Posted
August 21, 2023
Study Start
May 17, 2022
Primary Completion
July 26, 2022
Study Completion
September 9, 2022
Last Updated
May 22, 2025
Record last verified: 2025-05